Differential Regulation of LPS-Mediated VE-Cadherin Disruption in Human Endothelial Cells and the Underlying Signaling Pathways: A Mini Review.
VE-cadherin
adherens junction
endothelial hyperpermeability
internalization
lipopolysaccharide
tyrosine phosphorylation
Journal
Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250
Informations de publication
Date de publication:
2019
2019
Historique:
received:
30
07
2019
accepted:
31
10
2019
entrez:
24
1
2020
pubmed:
24
1
2020
medline:
24
1
2020
Statut:
epublish
Résumé
Endothelial cells lining the inner vascular wall form a monolayer that contributes to the selective permeability of endothelial barrier. This selective permeability is mainly regulated by an endothelium-specific adherens junctional protein, known as vascular endothelial-cadherin (VE-cadherin). In endothelial cells, the adherens junction comprises of VE-cadherin and its associated adhesion molecules such as p120, α-catenin, and β-catenin, in which α-catenin links cytoplasmic tails of VE-cadherin to actin cytoskeleton through β-catenin. Proinflammatory stimuli such as lipopolysaccharide (LPS) are capable of attenuating vascular integrity through the disruption of VE-cadherin adhesion in endothelial cells. To date, numerous studies demonstrated the disruption of adherens junction as a result of phosphorylation-mediated VE-cadherin disruption. However, the outcomes from these studies were inconsistent and non-conclusive as different cell fractions were used to examine the effect of LPS on the disruption of VE-cadherin. By using Western Blot, some studies utilized total protein lysate and reported decreased protein expression while some studies reported unchanged expression. Other studies which used membrane and cytosolic fractions of protein extract demonstrated decreased and increased VE-cadherin expression, respectively. Despite the irregularities, the results of immunofluorescence staining are consistent with the formation of intercellular gap. Besides that, the overall underlying disruptive mechanisms of VE-cadherin remain largely unknown. Therefore, this mini review will focus on different experiment approaches in terms of cell fractions used in different human endothelial cell studies, and relate these differences to the results obtained in Western blot and immunofluorescence staining in order to give some insights into the overall differential regulatory mechanisms of LPS-mediated VE-cadherin disruption and address the discrepancy in VE-cadherin expression.
Identifiants
pubmed: 31970155
doi: 10.3389/fcell.2019.00280
pmc: PMC6955238
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
280Informations de copyright
Copyright © 2020 Chan, Harith, Israf and Tham.
Références
J Cell Mol Med. 2013 Jun;17(6):800-14
pubmed: 23635013
Exp Cell Res. 1999 Oct 10;252(1):13-9
pubmed: 10502395
Stem Cell Res Ther. 2015 Dec 16;6:250
pubmed: 26674641
Biochem Biophys Res Commun. 2015 Dec 4-11;468(1-2):119-24
pubmed: 26529544
Microcirculation. 2006 Dec;13(8):693-708
pubmed: 17085428
Vascul Pharmacol. 2015 Sep;72:43-52
pubmed: 25956732
Cell Physiol Biochem. 2017;42(2):761-779
pubmed: 28628912
Circ Res. 2017 Jan 6;120(1):179-206
pubmed: 28057793
Cell Metab. 2005 Jan;1(1):15-25
pubmed: 16054041
Eur J Cell Biol. 2017 Oct;96(7):695-704
pubmed: 28818340
Shock. 2015 Jul;44(1):58-64
pubmed: 25895142
Redox Biol. 2017 Aug;12:438-455
pubmed: 28319894
Am J Respir Cell Mol Biol. 2016 Jun;54(6):769-81
pubmed: 26551054
J Surg Res. 2016 May 1;202(1):87-94
pubmed: 27083952
Inflammation. 2019 Aug;42(4):1504-1510
pubmed: 31102123
Am J Physiol Lung Cell Mol Physiol. 2015 May 15;308(10):L1025-38
pubmed: 25795725
Stem Cell Res Ther. 2015 Mar 24;6:44
pubmed: 25888925
Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):223-32
pubmed: 18162609
J Physiol. 2001 Jun 1;533(Pt 2):433-45
pubmed: 11389203
J Cell Physiol. 2013 Jun;228(6):1295-303
pubmed: 23168683
Nat Commun. 2015 Apr 14;6:6656
pubmed: 25871545
J Biol Chem. 2010 Sep 17;285(38):29375-86
pubmed: 20634284
PLoS One. 2015 May 19;10(5):e0126640
pubmed: 25992563
Life Sci. 2018 Oct 1;210:86-95
pubmed: 30171880
Crit Care Med. 2009 May;37(5):1735-43
pubmed: 19325485
Prostaglandins Leukot Essent Fatty Acids. 1993 Dec;49(6):955-8
pubmed: 8140123
Sci Rep. 2018 Jul 2;8(1):9963
pubmed: 29967433
Lab Invest. 2019 Apr;99(4):577-587
pubmed: 30659271
J Cell Physiol. 2015 Mar;230(3):691-701
pubmed: 25200929
Exp Cell Res. 2018 Apr 1;365(1):97-105
pubmed: 29481792
Oxid Med Cell Longev. 2019 Mar 10;2019:4957646
pubmed: 30984337
Braz J Med Biol Res. 2018 Aug 06;51(10):e7579
pubmed: 30088541
Biomed Pharmacother. 2019 Jul;115:108971
pubmed: 31102910
J Surg Res. 2016 Feb;200(2):619-30
pubmed: 26432471
J Biol Chem. 2011 May 13;286(19):16958-66
pubmed: 21454513
FASEB J. 2015 Mar;29(3):868-81
pubmed: 25404710
Aging (Albany NY). 2009 Aug 15;1(9):771-83
pubmed: 20157566
Cell Mol Life Sci. 2015 Dec;72(24):4849-66
pubmed: 26112597
ScientificWorldJournal. 2011 May 05;11:1056-67
pubmed: 21552771
PLoS One. 2016 Mar 22;11(3):e0152166
pubmed: 27002329
Exp Cell Res. 2012 Aug 15;318(14):1673-84
pubmed: 22659162
Ann N Y Acad Sci. 2008 Mar;1123:134-45
pubmed: 18375586
Int J Biochem Cell Biol. 2003 Jun;35(6):881-900
pubmed: 12676174
Inflamm Res. 2016 Mar;65(3):213-24
pubmed: 26681130